US EditionDiorasis, Northway Biotech team up on glaucoma gene therapy
Summary by Pharmaceutical Business Review
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Diorasis, Northway Biotech team up on glaucoma gene therapy
This collaboration is said to result in a “scalable” cGMP production process for DTx’s AAV-based gene therapy candidate targeting open angle glaucoma. As part of this partnership, Northway The post Diorasis, Northway Biotech team up on glaucoma gene therapy development appeared first on Pharmaceutical Business review.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium